0 items USD 0.00Search
- Did you mean
- familiar adenovirus polypeptides
Your search for "Familial Adenomatous Polyposis" gave back 3299 results.
Publisher' newest research report, the “Familial Chylomicronemia Syndrome Therapeutics Industry Forecast” looks at past sales and reviews total...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Highlights The global Family Asthma Management Product market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Highlights The global Homozygous Familial Hypercholesterolemia Epidemiology market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Publisher' newest research report, the “Family Asthma Management Product Industry Forecast” looks at past sales and reviews total world Family...
Catalog:
LPI
January 2023
Price: USD 3,660.00
According to our Publisher latest study, the global Familial Chylomicronemia Syndrome Therapeutics market size was valued at USD million in 2022 and...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The global Progressive Familial Intrahepatic Cholestasis Cholestyramine Treatment market is projected to reach US$ million in 2029, increasing from...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Progressive familial intrahepatic cholestasis (PFIC) type 2 is a rare genetic disorder that has no curative medication. Key players in the market...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Familial amyloid polyneuropathy (FAP) or transthyretin (TTR) amyloid neuropathy are a rare group of autosomal dominant diseases caused by the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
According to our latest research, the global Single Family Green Building market size will reach USD 314400 million in 2029, growing at a CAGR of 14...
Catalog:
GIR
May 2023
Price: USD 3,480.00
The global Chromosomal Microarray (CMA) Familial Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
According to our Publisher latest study, the global Progressive Familial Intrahepatic Cholestasis Cholestyramine Treatment market size was valued at...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Highlights The global Familial Chylomicronemia Syndrome Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Familial Amyloid Polyneuropathy (FAP) is a progressive, disabling and life-threatening polyneuropathy affecting the peripheral and autonomic nervous...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Familial Amyloid Polyneuropathy Therapeutic market will...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
October 2022
Price: USD 2,000.00
